Effect of Testosterone on Inflammatory Markers in the Development of Early Atherogenesis in the Testicular-Feminized Mouse Model

REFERENCES

• Jones TH, Saad F. The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process. Atherosclerosis 2009;207:318–327.
   PubMed Web of Science ®Google Scholar
• Saad F, Gooren LJ, Haider A, Yassin A. A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate. J Androl 2008;29:102–105.
   PubMed Web of Science ®Google Scholar
• Jones TH, Arver S, Behre HM, Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care 2011;34:828–837.
   PubMed Web of Science ®Google Scholar
• Khaw KT, Barrett-Connor E. Blood pressure and endogenous testosterone in men: an inverse relationship. J Hypertens 1988;6:329–332.
   PubMed Web of Science ®Google Scholar
• English KM, Steeds RP, Jones TH, Diver MJ, Channer KS. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study. Circulation 2000;102:1906–1911.
   PubMed Web of Science ®Google Scholar
• Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS, Jones TH. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocr Metab 2004;89:3313–3318.
   PubMed Web of Science ®Google Scholar
• Malkin CJ, Pugh PJ, Morris PD, Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Heart 2004;90:871–876.
   PubMed Web of Science ®Google Scholar
• Bruck B, Brehme U, Gugel N, Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 1997;17:2192–2199.
   PubMedGoogle Scholar
• Alexandersen P, Haarbo J, Byrjalsen I, Lawaetz H, Christiansen C. Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circulation Res 1999;84:813–819.
   PubMed Web of Science ®Google Scholar
• Nathan L, Shi W, Dinh H, Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase. Proc Natl Acad Sci USA 2001;98:3589–3593.
   PubMed Web of Science ®Google Scholar
• Nettleship JE, Jones TH, Channer KS, Jones RD. Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse: an effect that is independent of the classic androgen receptor. Circulation 2007;116:2427–2434.
   PubMed Web of Science ®Google Scholar
• Bourghardt J, Wilhelmson ASK, Alexanderson C, Androgen receptor-dependent and independent atheroprotection by testosterone in male mice. Endocrinology 2010;151:5428–5437.
   PubMed Web of Science ®Google Scholar
• Combadiere C, Potteaux S, Gao JL, Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 2003;107:1009–1016.
   PubMed Web of Science ®Google Scholar
• Lesnik P, Haskell CA, Charo IF. Decreased atherosclerosis in CX3CR1−/− mice reveals a role for fractalkine in atherogenesis. J Clin Investig 2003;111:333–340.
   PubMed Web of Science ®Google Scholar
• Teupser D, Pavlides S, Tan M, Gutierrez-Ramos JC, Kolbeck R, Breslow JL. Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root. Proc Natl Acad Sci USA 2004;101:17795–17800.
   PubMed Web of Science ®Google Scholar
• Kimouli M, Miyakis S, Georgakopoulos P, Neofytou E, Achimastos AD, Spandidos DA. Polymorphisms of fractalkine receptor CX3CR1 gene in patients with symptomatic and asymptomatic carotid artery stenosis. J Atheroscler Thromb 2009;16:604–610.
   Google Scholar
• Bazan JF, Bacon KB, Hardiman G, A new class of membrane-bound chemokine with a CX3C motif. Nature 1997;385:640–644.
   PubMed Web of Science ®Google Scholar
• Wong BW, Wong D, McManus BM. Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease. Cardiovasc Pathol 2002;11:332–338.
   Google Scholar
• Lucas AD, Bursill C, Guzik TJ, Sadowski J, Channon KM, Greaves DR. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1). Circulation 2003;108:2498–2504.
   PubMed Web of Science ®Google Scholar
• Tacke F, Alvarez D, Kaplan TJ, Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Investig 2007;117:185–194.
   PubMed Web of Science ®Google Scholar
• Combadiere C, Potteaux S, Rodero M, Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 2008;117:1649–1657.
   PubMed Web of Science ®Google Scholar
• Hatakeyama H, Nishizawa M, Nakagawa A, Nakano S, Kigoshi T, Uchida K. Testosterone inhibits tumor necrosis factor-α-induced vascular cell adhesion molecule-1 expression in human aortic endothelial cells. FEBS Lett 2002;530:129–132.
   PubMed Web of Science ®Google Scholar
• Mukherjee TK, Dinh H, Chaudhuri G, Nathan L. Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis. Proc Natl Acad Sci USA 2002;99:4055–4060.
   PubMed Web of Science ®Google Scholar
• Norata GD, Tibolla G, Seccomandi PM, Poletti A, Catapano AL. Dihydrotestosterone decreases tumor necrosis factor-alpha and lipopolysaccharide-induced inflammatory response in human endothelial cells. J Clin Endocr Metab 2006;91:546–554.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang L, Jiang T, Effects of testosterone and 17-β-estradiol on TNF-α-induced E-selectin and VCAM-1 expression in endothelial cells: analysis of the underlying receptor pathways. Life Sci 2002;71:15–29.
   Google Scholar
• Death AK, McGrath KC, Sader MA, Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-kappa B-dependent pathway. Endocrinology 2004;145:1889–1897.
   Google Scholar
• Charest NJ, Zhou ZX, Lubahn DB, Olsen KL, Wilson EM, French FS. A frameshift mutation destabilizes androgen receptor messenger RNA in the Tfm mouse. Mol Endocrinol 1991;5:573–581.
   PubMedGoogle Scholar
• He WW, Kumar MV, Tindall DJ. A frame-shift mutation in the androgen receptor gene causes complete androgen insensitivity in the testicular-feminized mouse. Nucleic Acids Res 1991;19:2373–2378.
   PubMed Web of Science ®Google Scholar
• Murphy L, O’Shaughnessy PJ. Testicular steroidogenesis in the testicular feminized (Tfm) mouse: loss of 17 alpha-hydroxylase activity. J Endocrinol 1991;131:443–449.
   Google Scholar
• Le Goascogne C, Sannanes N, Gouezou M, Baulieu EE, Robel P. Suppressed expression of the cytochrome P45017 alpha protein in the testicular feminized (Tfm) mouse testes. J Endocrinol 1993;139:127–130.
   Google Scholar
• Jones RD, Pugh PJ, Hall J, Channer KS, Jones TH. Altered circulating hormone levels, endothelial function and vascular reactivity in the testicular feminised mouse. Eur J Endocrinol 2003;148:111–120.
   PubMed Web of Science ®Google Scholar
• Yesilova Z, Ozata M, Kocar IH, The effects of gonadotropin treatment on the immunological features of male patients with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2000;85:66–70.
   Google Scholar
• Ridker PM, Rifai PM, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000;101:2149–2153.
   PubMed Web of Science ®Google Scholar
• Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000;148(2):209–214.
   PubMed Web of Science ®Google Scholar
• Luc G, Bard JM, Juhan-Vague I, ; PRIME Study Group. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study. Arterioscler Thromb Vasc Biol 2003;23(7):1255–1261.
   PubMed Web of Science ®Google Scholar
• Esposito K, Giugliano D. Diet and inflammation: a link to metabolic and cardiovascular diseases. Eur Heart J 2006;27(1):15–20.
   PubMed Web of Science ®Google Scholar
• Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6(10):772–783.
   PubMed Web of Science ®Google Scholar
• Jones TH. Testosterone associations with erectile dysfunction, diabetes, and the metabolic syndrome. Eur Urol Suppl 2007;6:847–857.
   Web of Science ®Google Scholar
• Zitzmann M, Erren M, Kamischke A, Simoni M, Nieschlag E. Endogenous progesterone and the exogenous progestin norethisterone enanthate are associated with a proinflammatory profile in healthy men. J Clin Endocrinol Metab 2005;90:6603–6608.
   Google Scholar
• Kalinchenko SY, Tishova YA, Mskhalaya GJ, Gooren LJ, Giltay EJ, Saad F. Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study. Clin Endocrinol 2010;73(5):602–612.
   PubMed Web of Science ®Google Scholar
• Spinedi E, Suescun MO, Hadid R, Daneva T, Gaillard RC. Effects of gonadectomy and sex hormone therapy on the endotoxin-stimulated hypothalamo-pituitary-adrenal axis: evidence for a neuroendocrine-immunological sexual dimorphism. Endocrinology 1992;131:2430–2436.
   PubMed Web of Science ®Google Scholar
• Dansky HM, Charlton SA, Harper MM, Smith JDT. B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA 1997;94:4642–4646.
   PubMed Web of Science ®Google Scholar
• Ni M, Wang Y, Zhang M, Atherosclerotic plaque disruption induced by stress and lipopolysaccharide in apolipoprotein E knockout mice. Am J PhysiolHeart Circ Physiol 2009;296:H1598–606.
   Google Scholar
• Patel A, Jagadesham VP, Porter KE, Scott DJA, Carding SR. Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease. Eur J Vasc Endovasc Surg 2008;36:20–27.
   Google Scholar